Avidian Wealth Enterprises’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $823K | Buy |
|
|||||
|
2025
Q2 | $825K | Buy |
|
|||||
|
2025
Q1 | $764K | Buy |
|
|||||
|
2024
Q4 | $842K | Sell |
|
|||||
|
2024
Q3 | $1.19M | Sell |
|
|||||
|
2024
Q2 | $1.45M | Buy |
|
|||||
|
2024
Q1 | $1.27M | Buy |
|
|||||
|
2023
Q4 | $814K | Buy |
|
|||||
|
2023
Q3 | $672K | Sell |
|
|||||
|
2023
Q2 | $1.26M | Sell |
|
|||||
|
2023
Q1 | $1.4M | Sell |
|
|||||
|
2022
Q4 | $1.38M | Buy |
|
|||||
|
2022
Q3 | $994K | Buy |
|
|||||
|
2022
Q2 | $1.02M | Buy |
|
|||||
|
2022
Q1 | $989K | Buy |
|
|||||
|
2021
Q4 | $805K | Sell |
|
|||||
|
2021
Q3 | $713K | Sell |
|
|||||
|
2021
Q2 | $682K | Buy |
|
|||||
|
2021
Q1 | $463K | Buy |
|
|||||
|
2020
Q4 | $427K | Buy |
|